FDA Announces Concerns Regarding CBD Products and a Punt to Congress
As you may be aware, over four years after the federal government signed the 2018 Farm Bill into law, last week, on January 26, 2023, the FDA announced that it will not engage in any rulemaking processes related to CBD or other similar cannabis-derived compounds because it is unable to safely regulate such compounds under its existing regulatory processes. Additionally,
Hilary St. Jean
January 31, 2023